Figure 2B demonstrates the upregulation of RAB3B in tumor samples of Adrenocortical carcinoma (ACC), BLCA, Breast invasive carcinoma (BRCA), CESC, CHOL, Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC), ESCA, HNSC, Kidney Chromophobe (KICH), Kidney renal papillary cell carcinoma (KIRP), LIHC, LUAD, LUSC, Pancreatic adenocarcinoma (PAAD), PRAD, STAD, Testicular Germ Cell Tumors (TGCT), THCA, Thymoma (THYM), UCEC, and Uterine Carcinosarcoma (UCS). This evidence concerns the gene RAB3B and prostate adenocarcinoma.